Related references
Note: Only part of the references are listed.Association between occult hepatitis B infection and the risk of hepatocellular carcinoma: a meta-analysis
Yu Shi et al.
LIVER INTERNATIONAL (2012)
Seasonal Variation in TP53 R249S-Mutated Serum DNA with Aflatoxin Exposure and Hepatitis B Virus Infection
Stephanie Villar et al.
ENVIRONMENTAL HEALTH PERSPECTIVES (2011)
Significance of hepatitis B virus genotypes and mutations in the development of hepatocellular carcinoma in Asia
Henry Lik-Yuen Chan
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2011)
Hepatitis B virus x protein in the pathogenesis of hepatitis B virus-induced hepatocellular carcinoma
Michael C. Kew
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2011)
MEGA5: Molecular Evolutionary Genetics Analysis Using Maximum Likelihood, Evolutionary Distance, and Maximum Parsimony Methods
Koichiro Tamura et al.
MOLECULAR BIOLOGY AND EVOLUTION (2011)
Interaction of Mutant Hepatitis B X Protein With p53 Tumor Suppressor Protein Affects Both Transcription and Cell Survival
Shoba Iyer et al.
MOLECULAR CARCINOGENESIS (2011)
Increase in Female Liver Cancer in The Gambia, West Africa: Evidence from 19 Years of Population-Based Cancer Registration (1988-2006)
Dominique Sighoko et al.
PLOS ONE (2011)
Effects of the TP53 p.R249S mutant on proliferation and clonogenic properties in human hepatocellular carcinoma cell lines: interaction with hepatitis B virus X protein
Doriane A. Gouas et al.
CARCINOGENESIS (2010)
Cooperation of tumor-derived HBx mutants and p53-249ser mutant in regulating cell proliferation, anchorage-independent growth and aneuploidy in a telomerase-immortalized normal human hepatocyte-derived cell line
Weidong Jiang et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Epidemic History and Evolutionary Dynamics of Hepatitis B Virus Infection in Two Remote Communities in Rural Nigeria
Joseph C. Forbi et al.
PLOS ONE (2010)
Epidemiology of chronic hepatitis B virus infection, hepatocellular carcinoma, and hepatitis B virus-induced hepatocellular carcinoma
M. C. Kew
PATHOLOGIE BIOLOGIE (2010)
Prospective Evaluation of Hepatitis B 1762T/1764A Mutations on Hepatocellular Carcinoma Development in Shanghai, China
Jian-Min Yuan et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2009)
The aflatoxin-induced TP53 mutation at codon 249 (R249S): Biomarker of exposure, early detection and target for therapy
Doriane Gouas et al.
CANCER LETTERS (2009)
HBV A1762T, G1764A Mutations Are a Valuable Biomarker for Identifying a Subset of Male HBsAg Carriers at Extremely High Risk of Hepatocellular Carcinoma: A Prospective Study
Zhong-Liao Fang et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
20 Years into the Gambia Hepatitis Intervention Study: Assessment of Initial Hypotheses and Prospects for Evaluation of Protective Effectiveness Against Liver Cancer
Simonetta Viviani et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2008)
COOH-terminal truncated HBV X protein plays key role in hepatocarcinogenesis
Ning-Fang Ma et al.
CLINICAL CANCER RESEARCH (2008)
Aflatoxin Exposure and Viral Hepatitis in the Etiology of Liver Cirrhosis in The Gambia, West Africa
Mark H. Kuniholm et al.
ENVIRONMENTAL HEALTH PERSPECTIVES (2008)
Application of a novel, rapid, and sensitive oligonucleotide ligation assay for detection of cancer-predicting mutations in the precore and basal core promoter of hepatitis B virus
M. E. Mendy et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2008)
Hepatitis B virus integration, fragile sites, and hepatocarcinogenesis
Mark A. Feitelson et al.
CANCER LETTERS (2007)
Circulating free DNA in plasma or serum as biomarker of carcinogenesis: Practical aspects and biological significance
Emmanuelle Gormally et al.
MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH (2007)
Molecular epidemiology of human liver cancer: insights into etiology, pathogenesis and prevention from The Gambia, West Africa
Gregory D. Kirk et al.
CARCINOGENESIS (2006)
Therapeutic implications of hepatitis B virus genotypes
CJ Liu et al.
LIVER INTERNATIONAL (2005)
Quantitative analysis of plasma TP53 249Ser-mutated DNA by electrospray ionization mass spectrometry
ME Lleonart et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2005)
249ser TP53 mutation in plasma DNA, hepatitis B viral infection, and risk of hepatocellular carcinoma
GD Kirk et al.
ONCOGENE (2005)
Hepatitis B 1762T/1764A mutations, hepatitis C infection, and codon 249 p53 mutations in hepatocellular carcinomas from Thailand
SY Kuang et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2005)
Relationship of genotypes of hepatitis B virus to mutations, disease progression and response to antiviral therapy
A Kramvis et al.
JOURNAL OF VIRAL HEPATITIS (2005)
Distinctive sequence characteristics of subgenotype A1 isolates of hepatitis B virus from South Africa
GC Kimbi et al.
JOURNAL OF GENERAL VIROLOGY (2004)
Epidemiological and sequence differences between two subtypes (Ae and Aa) of hepatitis B virus genotype A
F Sugauchi et al.
JOURNAL OF GENERAL VIROLOGY (2004)
Ser-249 TP53 mutation in tumour and plasma DNA of hepatocellular carcinoma patients from a high incidence area in the Gambia, West Africa
K Szymanska et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
The Gambia Liver Cancer Study: Infection with hepatitis B and C and the risk of hepatocellular carcinoma in West Africa
GD Kirk et al.
HEPATOLOGY (2004)
Genetic diversity of hepatitis B virus strains derived worldwide: Genotypes, subgenotypes, and HBsAg subtypes
H Norder et al.
INTERVIROLOGY (2004)
Sequence variation upstream of precore translation initiation codon reduces hepatitis B virus e antigen production
SH Ahn et al.
GASTROENTEROLOGY (2003)
Hepatocellular carcinoma
S Badvie
POSTGRADUATE MEDICAL JOURNAL (2000)
Share Paper
